Display options
Share it on

J Am Acad Dermatol. 2021 Jun;84(6):e293-e294. doi: 10.1016/j.jaad.2021.02.056. Epub 2021 Feb 25.

Response to: "Comment on 'The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries'".

Journal of the American Academy of Dermatology

Esther E Freeman, Devon E McMahon, Seemal R Desai, Lindy P Fox

Affiliations

  1. Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: [email protected].
  2. Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  3. The University of Texas Southwestern Medical Center, Dallas, Texas; Innovative Dermatology, Plano, Texas.
  4. Department of Dermatology, University of California San Francisco, San Francisco, California.

PMID: 33640507 PMCID: PMC7905375 DOI: 10.1016/j.jaad.2021.02.056

[No abstract available.]

Conflict of interest statement

Conflicts of interest Drs Freeman, Desai, and Fox are members of the AAD COVID-19 Ad Hoc Task Force. Author McMahon has no conflicts of interest to declare.

References

  1. J Am Acad Dermatol. 2020 Sep;83(3):e261-e266 - PubMed
  2. J Am Acad Dermatol. 2021 Jun;84(6):e291-e292 - PubMed
  3. Br J Dermatol. 2020 Sep;183(3):593-595 - PubMed
  4. Dermatol Clin. 2012 Jan;30(1):53-9, viii - PubMed
  5. J Am Acad Dermatol. 2021 Feb;84(2):505-507 - PubMed

MeSH terms

Publication Types